Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients. Sorensen P S, Koch-Henriksen N, Petersen T, Ravnborg M, Oturai A, Sellebjerg F J Neurol. 2014 Apr 12. Epub 2014 Apr 12. PMID: 24728334. Abstract CommentRecommendBookmarkWatch
